The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human phase 1 study of GC1118, a novel monoclonal antibody inhibiting epidermal growth factor receptor (EGFR), in patients with advanced solid tumors.
 
Keun Wook Lee
Research Funding - AstraZeneca (Inst); Green Cross (Inst); MSD (Inst)
 
Do-Youn Oh
Consulting or Advisory Role - AstraZeneca; Baxalta; Lilly; Merck; Novartis
Research Funding - Mogam Biotechnology Research Institue (Inst)
 
Sae-Won Han
No Relationships to Disclose
 
Jin Won Kim
No Relationships to Disclose
 
Jung-Won Shin
No Relationships to Disclose
 
Seong-Jin Jo
Consulting or Advisory Role - Chong Kun Dang Pharmaceutical
Research Funding - Janssen-Ortho; Pfizer
 
Na Hyung Kim
Employment - Green Cross
 
Ahmi Woo
Employment - Green Cross
Travel, Accommodations, Expenses - Green Cross
 
Jonghwa Won
Employment - Green Cross
Stock and Other Ownership Interests - Green Cross
Research Funding - Green Cross
Travel, Accommodations, Expenses - Green Cross
 
Seokyung Hahn
Consulting or Advisory Role - Bristol-Myers Squibb; Green Cross; Roche
Research Funding - Actelion (Inst); Novartis (Inst)
 
Howard Lee
Honoraria - Celltrion; GlaxoSmithKline; Pfizer
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Roche
Research Funding - Boryung (Inst); Handok (Inst); Kwandong (Inst); Yuhan (Inst)
 
Woo Ho Kim
Consulting or Advisory Role - AstraZeneca; MSD
 
Yung-Jue Bang
Consulting or Advisory Role - Green Cross
Research Funding - Green Cross (Inst)